Metoprolol Succinate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Metoprolol Succinate
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Metoprolol Succinate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 34 USDMF, 17 CEP/COS, 13 EU WC, 17 NDC API, 26 Listed Suppliers, $ API Reference Price

51 API Suppliers
34 USDMF
17 CEP/COS
13 EU WC
17 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

185 FDF Dossiers, 95 FDA Orange Book, 30 Europe, 27 Australia, 33 Listed Dossiers

185 FDF Dossiers
95 FDA Orange Book
30 Europe
27 Australia
33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE
CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Evonik, 2 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 10 DKSH, 6 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 15 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 32 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 21 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

73 Coating Systems & Additives, 73 Fillers, Diluents & Binders, 42 Controlled & Modified Release, 38 Thickeners and Stabilizers, 38 Solubilizers, 32 Disintegrants & Superdisintegrants, 29 Direct Compression, 27 Granulation, 24 Lubricants & Glidants, 23 Film Formers & Plasticizers, 17 Topical, 16 Taste Masking, 14 Parenteral, 12 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 9 Emulsifying Agents, 9 Empty Capsules, 8 Rheology Modifiers, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

73 Coating Systems & Additives
73 Fillers, Diluents & Binders
42 Controlled & Modified Release
38 Thickeners and Stabilizers
38 Solubilizers
32 Disintegrants & Superdisintegrants
29 Direct Compression
27 Granulation
24 Lubricants & Glidants
23 Film Formers & Plasticizers
17 Topical
16 Taste Masking
14 Parenteral
12 Chewable & Orodispersible Aids
12 Co-Processed Excipients
9 Emulsifying Agents
9 Empty Capsules
8 Rheology Modifiers
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

32 NEWS #PharmaBuzz

32 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Finished Drug Prices

2 US Medicaid Prescriptions
12 Finished Drug Prices

MARKET PLACE

9 APIs, 1 FDF Dossiers

9 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 3 Health Canada Patents

8 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

2 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 47 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8SPIL

filter Patent Number Reset all filters

8 All

01 49504655

02 49700530

filter API Patent Reset all filters

8 All

01 8Blank

filter FDF Patent Reset all filters

8 All

01 8Y

filter Expiration Date Reset all filters

8 All

01 82035-07-09

Granules Metoprolol Succinate

Product Main Page

01

SPIL

METOPROLOL SUCCINATE

Biotech Digital Meet

Not Confirmed

SPIL

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9504655

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SPIL

METOPROLOL SUCCINATE

Biotech Digital Meet

Not Confirmed

SPIL

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9700530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SPIL

METOPROLOL SUCCINATE

Biotech Digital Meet

Not Confirmed

SPIL

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9700530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SPIL

METOPROLOL SUCCINATE

Biotech Digital Meet

Not Confirmed

SPIL

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9700530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

SPIL

METOPROLOL SUCCINATE

Biotech Digital Meet

Not Confirmed

SPIL

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9504655

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SPIL

METOPROLOL SUCCINATE

Biotech Digital Meet

Not Confirmed

SPIL

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9504655

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

SPIL

METOPROLOL SUCCINATE

Biotech Digital Meet

Not Confirmed

SPIL

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9700530

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SPIL

METOPROLOL SUCCINATE

Biotech Digital Meet

Not Confirmed

SPIL

Biotech Digital Meet

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-09

METOPROLOL SUCCINATE

US Patent Number : 9504655

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210428

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-09

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?